Ruzasvir

N/A

Report date: 2025/12/23 17:06:11
NME

Base Information

Drug NameRuzasvir
Drug Alias NameRuzasvirum鲁扎韦卢扎司韦MK-8408LX752BD95Y
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNonstructural protein 5A inhibitors
TargetsNonstructural protein 5A
Therapy Area/IndicationsLiver CirrhosisHepatitisLiver Diseases +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesRomania +[10] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesAtea Pharmaceuticals Inc
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsLiver CirrhosisHepatitis C, ChronicHepatitis C
Inactive IndicationsHepatitisLiver DiseasesDigestive System Diseases +[7] 

Other Information

ATC CodeN/A
Related LinksN/A